About Careers MedBlog Contact us

New Inexpensive Cancer Drug Launched by Cadila

by Savitha C Muppala on November 22, 2013 at 9:29 PM
Font : A-A+

 New Inexpensive Cancer Drug Launched by Cadila

Cadila Pharmaceuticals has just announced the entry of its new drug for lung cancer management. This is seen as an important development in the treatment of lung cancer.

The drug, Mycidac-C, can be used for victims suffering from a cancer sub-type - non-small cell lung cancer.


10 injections come at a price of Rs.4000 and the total expenditure for therapy to patients is estimated at Rs 40,000.

Cadila CMD Dr Rajiv Modi said, "Our drug is a significant breakthrough in the management of squamous non-small cell lung cancer (NSCLC), since the introduction of first line cancer drugs nearly 30 years ago."

According to Dr Modi, this drug can be used along with other cancer medication and trials on this drug has proved that it can boost median survival by over 40% in patients suffering from squamous NSCLC.

"It has taken us over a decade, a huge investment and a dedicated research and development team to develop this unique drug. We expect it to be available in the Indian market by December 2013. Thereafter, we will introduce it in other regions like SAARC countries and European markets over the next five years," Modi said.

Source: Medindia


Recommended Reading

Latest Cancer News

Two Years: Optimal Duration of Immunotherapy in Advanced Lung Cancer
Study suggests two-year immunotherapy treatment for advanced lung cancer may be reasonable
Hope for Lethal Brain Tumors: Targeted Therapy Delays Glioma Progression
A ray of hope for glioma patients as targeted therapy boosts treatment duration.
Is Adding Ribociclib to Hormone Therapy Improves Breast Cancer Outcomes
In patients with breast cancer combination therapy had increased invasive disease-free survival compared to those who were treated with the hormone therapy alone.
Antibody Treatment Proves Effective for Bile Duct Cancers
An antibody treatment helped shrink tumors in some patients with bile duct cancers.
Link Between Gut Microbiome and Precancerous Colon Polyps Identified
Comprehending the association between the gut microbiome and polyp growth sheds insights into potential screenings and treatments.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

New Inexpensive Cancer Drug Launched by Cadila Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests